SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-09-030007
Filing Date
2009-02-17
Accepted
2009-02-17 06:11:02
Documents
1
Group Members
INVUS PUBLIC EQUITIES ADVISORS, L.L.C.RAYMOND DEBBANEULYS, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT NO. 2 dsc13ga.htm SC 13G/A 112916
  Complete submission text file 0001193125-09-030007.txt   114854
Mailing Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010
Business Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010 212-994-8200
ANTIGENICS INC /DE/ (Subject) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-60419 | Film No.: 09606774
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 135 EAST 57, 30 TH FLOOR NEW YORK NY 10022
Business Address 135 EAST 57, 30 TH FLOOR NEW YORK NY 10022 212-317-7520
Invus Public Equities, LP (Filed by) CIK: 0001340097 (see all company filings)

IRS No.: 980420215
Type: SC 13G/A